Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial

A. Camerini, A. Morabito, A. Montanino, R. Bernabé, F. Grossi, R. Ramlau, T.-E. Ciuleanu, G.-L. Ceresoli, G. Pasello, F. de Marinis, J. Bosch-Barrera, P. Laundreau, S. Gautier, C. Ta Thanh Minh, D. Kowalski

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number100051
JournalESMO open
Volume6
Issue number2
DOIs
Publication statusPublished - 2021

Keywords

  • administration and dosage
  • carcinoma non-small-cell lung
  • frail
  • randomized controlled trial
  • vinorelbine

Cite this